BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25266038)

  • 21. [New therapeutic possibilities with drugs affecting serotonin receptors].
    Spigset O
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1700-4. PubMed ID: 1509427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healy's editorial on serotonin and depression does a disservice to psychiatrists.
    Langford AE
    BMJ; 2015 May; 350():h2508. PubMed ID: 25975809
    [No Abstract]   [Full Text] [Related]  

  • 23. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.
    Carrey N; Kutcher S
    J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent advances in neuropsychopharmacology of the central serotonin receptor].
    Yamawaki S; Hayakawa H
    Yakubutsu Seishin Kodo; 1992 Apr; 12(2):43-54. PubMed ID: 1441762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of serotonin metabolism and nonpsychotic psychiatric disorders.
    Csernansky JG; Sheline YI
    Ann Clin Psychiatry; 1993 Dec; 5(4):275-81. PubMed ID: 8312985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioligands for the study of brain 5-HT1A receptors in vivo.
    Pike VW; Halldin C; Wikström HV
    Prog Med Chem; 2001; 38():189-247. PubMed ID: 11774795
    [No Abstract]   [Full Text] [Related]  

  • 29. [The 5-HT1A receptors: from molecular biology to neuropsychiatric symptoms].
    Navinés R; Gómez E; Gastó C
    Actas Esp Psiquiatr; 2003; 31(5):272-83. PubMed ID: 14557952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do we know about serotonin?
    Jonnakuty C; Gragnoli C
    J Cell Physiol; 2008 Nov; 217(2):301-6. PubMed ID: 18651566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.
    Murphy DL
    Neuropsychopharmacology; 1990; 3(5-6):457-71. PubMed ID: 2078279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
    Whitaker-Azmitia PM
    New Biol; 1989 Nov; 1(2):145-8. PubMed ID: 2577368
    [No Abstract]   [Full Text] [Related]  

  • 34. [Genetic dysfunction of the serotonin receptor 5-HT2A in psychiatric disorders].
    Arranz B; Rosel P; Ramírez N; San L
    Actas Esp Psiquiatr; 2001; 29(2):131-8. PubMed ID: 11333532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders.
    Gingrich JA; Ansorge MS; Merker R; Weisstaub N; Zhou M
    CNS Spectr; 2003 Aug; 8(8):572-7. PubMed ID: 12907920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The developmental role of serotonin: news from mouse molecular genetics.
    Gaspar P; Cases O; Maroteaux L
    Nat Rev Neurosci; 2003 Dec; 4(12):1002-12. PubMed ID: 14618156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [5HT-moduline an new peptide specifically interactive with the serotonergic system: physiopathologic implications].
    Fillion G
    Ann Pharm Fr; 1998; 56(4):145-7. PubMed ID: 9770005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurotoxicity of the drug Ecstasy. Functional consequences of serotonergic hypoactivity].
    de Visme PG
    Ugeskr Laeger; 1998 Oct; 160(42):6088-91. PubMed ID: 9800515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of serotonergic agents in the clinical assessment of central serotonin function.
    Murphy DL; Mueller EA; Garrick NA; Aulakh CS
    J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m-Chlorophenylpiperazine as a probe of serotonin function.
    Kahn RS; Wetzler S
    Biol Psychiatry; 1991 Dec; 30(11):1139-66. PubMed ID: 1663792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.